11-63096103-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136506.2(SLC22A24):āc.958G>Cā(p.Val320Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000048 in 1,540,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001136506.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A24 | NM_001136506.2 | c.958G>C | p.Val320Leu | missense_variant | 6/10 | ENST00000612278.4 | NP_001129978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A24 | ENST00000612278.4 | c.958G>C | p.Val320Leu | missense_variant | 6/10 | 5 | NM_001136506.2 | ENSP00000480336 | P4 | |
SLC22A24 | ENST00000417740.5 | c.958G>C | p.Val320Leu | missense_variant | 6/10 | 5 | ENSP00000396586 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000195 AC: 3AN: 153492Hom.: 0 AF XY: 0.0000123 AC XY: 1AN XY: 81428
GnomAD4 exome AF: 0.0000454 AC: 63AN: 1388744Hom.: 0 Cov.: 27 AF XY: 0.0000452 AC XY: 31AN XY: 685572
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2022 | The c.958G>C (p.V320L) alteration is located in exon 6 (coding exon 6) of the SLC22A24 gene. This alteration results from a G to C substitution at nucleotide position 958, causing the valine (V) at amino acid position 320 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at